Global Transfection Reagents Market

Transfection Reagents Comprehensive Study by Type (Reagents, Instruments), Application (Biomedical Research, Gene Expression Studies, Cancer Research, Transgenic Model, Protein Production, Therapeutic Delivery), End Users (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies), Method (Biochemical, Calcium Phosphate, Lipofection, DEAE-dextran, Dendrimers, Physical, Electroporation, Nucleofection, Viral, Others) Players and Region - Global Market Outlook to 2026

Transfection Reagents Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 7.4%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Transfection Reagents Market Scope
With Advancements in the healthcare industry, it has been witnessed that transfection reagents played an important role in the study of gene function & regulation, mutational analysis and biochemical characterization of gene products. The Transfection reagents market has high growth prospects due to its high-efficiency, low-toxicity transfection in many cells. Additionally, the growing popularity of biopharmaceuticals and the ongoing development of drug delivery systems propelled the transfection reagents market. Moreover, a growing trend in the transfection reagents market has been witnessed with respect to the demand for advanced techniques such are stable and transient transfection expected to fuel the market growth during the forecasted period.

According to AMA, the Global Transfection Reagents market is expected to see growth rate of 7.4% and may see market size of USD1358.9 Million by 2026.

In the Transfection Reagents market, it has been observed that most of the manufacturing companies are providing innovating solutions for the delivery of nucleic acids in research, bio-production, and therapeutics. It also involved in improving viability and morphology after transfection for more relevant data. They rely on strategies such as mergers & acquisitions, product development, geographical expansion, technological innovation and sourcing strategies to enhance their market share. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Transfection Reagents market throughout the predicted period.

Thermo Fisher Scientific Inc. (United States), Promega Corporation (United States), Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Polyplus-transfection SA (France), Bio-Rad Laboratories (United States), Lonza Group (Switzerland), Sigma-Aldrich Corporation (United States), Mirus Bio LLC (United States) and MaxCyte Inc. (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Transfection Reagents market by Type (Reagents and Instruments), by Application (Biomedical Research, Gene Expression Studies, Cancer Research, Transgenic Model, Protein Production and Therapeutic Delivery) and Region with country level break-up.

On the basis of geography, the market of Transfection Reagents has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.

In May 2018, Altogen Biosystems launched a cGMP-grade nanoparticle transfection reagent for In Vivo Delivery. These innovative products beneficial for high transfection efficiency, reproducibility and robustness approach for medical applications. It is also beneficial for a new business portfolio and raises market penetration.


Market Trend
  • Value-Oriented Customers
  • The rapid Progress of Cell and Gene Therapies Boost the Market

Market Drivers
  • Increasing Incidence of Cancer Patients Globally
  • Growing Research Activities in Cell Science.
  • Upsurge Demand for Nano-Science Technology

Opportunities
  • Technological Advancements in Transfection Technology Such as Car-T, Crispr-Cas9 and Others.
  • Rising in R&D Investments and Research Activities Boost the Pharmaceutical and Biotech Companies

Restraints
  • High Cost Associated with Transfection Reagent.
  • Stringent Restriction upon Sale of Commercial Kits

Challenges
  • Threats of Cytotoxicity in Transfection.
  • Transfection in Hard-to-Transfect Cells is Anticipated to Challenge the Market


Key Target Audience
Transfection Reagent Manufacturers, Transfection Reagent Provider, End-Use Market Participants of Different Segments of Transfection Reagent, Government and Research Organizations, R&D Institutions and Others

Report Objectives / Segmentation Covered

By Type
  • Reagents
  • Instruments
By Application
  • Biomedical Research
  • Gene Expression Studies
  • Cancer Research
  • Transgenic Model
  • Protein Production
  • Therapeutic Delivery
By End Users
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies

By Method
  • Biochemical
  • Calcium Phosphate
  • Lipofection
  • DEAE-dextran
  • Dendrimers
  • Physical
  • Electroporation
  • Nucleofection
  • Viral
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Cancer Patients Globally
      • 3.2.2. Growing Research Activities in Cell Science.
      • 3.2.3. Upsurge Demand for Nano-Science Technology
    • 3.3. Market Challenges
      • 3.3.1. Threats of Cytotoxicity in Transfection.
      • 3.3.2. Transfection in Hard-to-Transfect Cells is Anticipated to Challenge the Market
    • 3.4. Market Trends
      • 3.4.1. Value-Oriented Customers
      • 3.4.2. The rapid Progress of Cell and Gene Therapies Boost the Market
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Transfection Reagents, by Type, Application, End Users, Method and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Transfection Reagents (Value)
      • 5.2.1. Global Transfection Reagents by: Type (Value)
        • 5.2.1.1. Reagents
        • 5.2.1.2. Instruments
      • 5.2.2. Global Transfection Reagents by: Application (Value)
        • 5.2.2.1. Biomedical Research
        • 5.2.2.2. Gene Expression Studies
        • 5.2.2.3. Cancer Research
        • 5.2.2.4. Transgenic Model
        • 5.2.2.5. Protein Production
        • 5.2.2.6. Therapeutic Delivery
      • 5.2.3. Global Transfection Reagents by: End Users (Value)
        • 5.2.3.1. Academic & Research Institutes
        • 5.2.3.2. Pharmaceutical & Biotechnology Companies
      • 5.2.4. Global Transfection Reagents by: Method (Value)
        • 5.2.4.1. Biochemical
        • 5.2.4.2. Calcium Phosphate
        • 5.2.4.3. Lipofection
        • 5.2.4.4. DEAE-dextran
        • 5.2.4.5. Dendrimers
        • 5.2.4.6. Physical
        • 5.2.4.7. Electroporation
        • 5.2.4.8. Nucleofection
        • 5.2.4.9. Viral
        • 5.2.4.10. Others
      • 5.2.5. Global Transfection Reagents Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Transfection Reagents (Price)
      • 5.3.1. Global Transfection Reagents by: Type (Price)
  • 6. Transfection Reagents: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Promega Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. QIAGEN N.V. (Netherlands)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Polyplus-transfection SA (France)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bio-Rad Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Lonza Group (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sigma-Aldrich Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Mirus Bio LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. MaxCyte Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Transfection Reagents Sale, by Type, Application, End Users, Method and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Transfection Reagents (Value)
      • 7.2.1. Global Transfection Reagents by: Type (Value)
        • 7.2.1.1. Reagents
        • 7.2.1.2. Instruments
      • 7.2.2. Global Transfection Reagents by: Application (Value)
        • 7.2.2.1. Biomedical Research
        • 7.2.2.2. Gene Expression Studies
        • 7.2.2.3. Cancer Research
        • 7.2.2.4. Transgenic Model
        • 7.2.2.5. Protein Production
        • 7.2.2.6. Therapeutic Delivery
      • 7.2.3. Global Transfection Reagents by: End Users (Value)
        • 7.2.3.1. Academic & Research Institutes
        • 7.2.3.2. Pharmaceutical & Biotechnology Companies
      • 7.2.4. Global Transfection Reagents by: Method (Value)
        • 7.2.4.1. Biochemical
        • 7.2.4.2. Calcium Phosphate
        • 7.2.4.3. Lipofection
        • 7.2.4.4. DEAE-dextran
        • 7.2.4.5. Dendrimers
        • 7.2.4.6. Physical
        • 7.2.4.7. Electroporation
        • 7.2.4.8. Nucleofection
        • 7.2.4.9. Viral
        • 7.2.4.10. Others
      • 7.2.5. Global Transfection Reagents Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Transfection Reagents (Price)
      • 7.3.1. Global Transfection Reagents by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Transfection Reagents: by Type(USD Million)
  • Table 2. Transfection Reagents Reagents , by Region USD Million (2015-2020)
  • Table 3. Transfection Reagents Instruments , by Region USD Million (2015-2020)
  • Table 4. Transfection Reagents: by Application(USD Million)
  • Table 5. Transfection Reagents Biomedical Research , by Region USD Million (2015-2020)
  • Table 6. Transfection Reagents Gene Expression Studies , by Region USD Million (2015-2020)
  • Table 7. Transfection Reagents Cancer Research , by Region USD Million (2015-2020)
  • Table 8. Transfection Reagents Transgenic Model , by Region USD Million (2015-2020)
  • Table 9. Transfection Reagents Protein Production , by Region USD Million (2015-2020)
  • Table 10. Transfection Reagents Therapeutic Delivery , by Region USD Million (2015-2020)
  • Table 11. Transfection Reagents: by End Users(USD Million)
  • Table 12. Transfection Reagents Academic & Research Institutes , by Region USD Million (2015-2020)
  • Table 13. Transfection Reagents Pharmaceutical & Biotechnology Companies , by Region USD Million (2015-2020)
  • Table 14. Transfection Reagents: by Method(USD Million)
  • Table 15. Transfection Reagents Biochemical , by Region USD Million (2015-2020)
  • Table 16. Transfection Reagents Calcium Phosphate , by Region USD Million (2015-2020)
  • Table 17. Transfection Reagents Lipofection , by Region USD Million (2015-2020)
  • Table 18. Transfection Reagents DEAE-dextran , by Region USD Million (2015-2020)
  • Table 19. Transfection Reagents Dendrimers , by Region USD Million (2015-2020)
  • Table 20. Transfection Reagents Physical , by Region USD Million (2015-2020)
  • Table 21. Transfection Reagents Electroporation , by Region USD Million (2015-2020)
  • Table 22. Transfection Reagents Nucleofection , by Region USD Million (2015-2020)
  • Table 23. Transfection Reagents Viral , by Region USD Million (2015-2020)
  • Table 24. Transfection Reagents Others , by Region USD Million (2015-2020)
  • Table 25. South America Transfection Reagents, by Country USD Million (2015-2020)
  • Table 26. South America Transfection Reagents, by Type USD Million (2015-2020)
  • Table 27. South America Transfection Reagents, by Application USD Million (2015-2020)
  • Table 28. South America Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 29. South America Transfection Reagents, by Method USD Million (2015-2020)
  • Table 30. Brazil Transfection Reagents, by Type USD Million (2015-2020)
  • Table 31. Brazil Transfection Reagents, by Application USD Million (2015-2020)
  • Table 32. Brazil Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 33. Brazil Transfection Reagents, by Method USD Million (2015-2020)
  • Table 34. Argentina Transfection Reagents, by Type USD Million (2015-2020)
  • Table 35. Argentina Transfection Reagents, by Application USD Million (2015-2020)
  • Table 36. Argentina Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 37. Argentina Transfection Reagents, by Method USD Million (2015-2020)
  • Table 38. Rest of South America Transfection Reagents, by Type USD Million (2015-2020)
  • Table 39. Rest of South America Transfection Reagents, by Application USD Million (2015-2020)
  • Table 40. Rest of South America Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 41. Rest of South America Transfection Reagents, by Method USD Million (2015-2020)
  • Table 42. Asia Pacific Transfection Reagents, by Country USD Million (2015-2020)
  • Table 43. Asia Pacific Transfection Reagents, by Type USD Million (2015-2020)
  • Table 44. Asia Pacific Transfection Reagents, by Application USD Million (2015-2020)
  • Table 45. Asia Pacific Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 46. Asia Pacific Transfection Reagents, by Method USD Million (2015-2020)
  • Table 47. China Transfection Reagents, by Type USD Million (2015-2020)
  • Table 48. China Transfection Reagents, by Application USD Million (2015-2020)
  • Table 49. China Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 50. China Transfection Reagents, by Method USD Million (2015-2020)
  • Table 51. Japan Transfection Reagents, by Type USD Million (2015-2020)
  • Table 52. Japan Transfection Reagents, by Application USD Million (2015-2020)
  • Table 53. Japan Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 54. Japan Transfection Reagents, by Method USD Million (2015-2020)
  • Table 55. India Transfection Reagents, by Type USD Million (2015-2020)
  • Table 56. India Transfection Reagents, by Application USD Million (2015-2020)
  • Table 57. India Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 58. India Transfection Reagents, by Method USD Million (2015-2020)
  • Table 59. South Korea Transfection Reagents, by Type USD Million (2015-2020)
  • Table 60. South Korea Transfection Reagents, by Application USD Million (2015-2020)
  • Table 61. South Korea Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 62. South Korea Transfection Reagents, by Method USD Million (2015-2020)
  • Table 63. Taiwan Transfection Reagents, by Type USD Million (2015-2020)
  • Table 64. Taiwan Transfection Reagents, by Application USD Million (2015-2020)
  • Table 65. Taiwan Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 66. Taiwan Transfection Reagents, by Method USD Million (2015-2020)
  • Table 67. Australia Transfection Reagents, by Type USD Million (2015-2020)
  • Table 68. Australia Transfection Reagents, by Application USD Million (2015-2020)
  • Table 69. Australia Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 70. Australia Transfection Reagents, by Method USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Transfection Reagents, by Type USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Transfection Reagents, by Application USD Million (2015-2020)
  • Table 73. Rest of Asia-Pacific Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 74. Rest of Asia-Pacific Transfection Reagents, by Method USD Million (2015-2020)
  • Table 75. Europe Transfection Reagents, by Country USD Million (2015-2020)
  • Table 76. Europe Transfection Reagents, by Type USD Million (2015-2020)
  • Table 77. Europe Transfection Reagents, by Application USD Million (2015-2020)
  • Table 78. Europe Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 79. Europe Transfection Reagents, by Method USD Million (2015-2020)
  • Table 80. Germany Transfection Reagents, by Type USD Million (2015-2020)
  • Table 81. Germany Transfection Reagents, by Application USD Million (2015-2020)
  • Table 82. Germany Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 83. Germany Transfection Reagents, by Method USD Million (2015-2020)
  • Table 84. France Transfection Reagents, by Type USD Million (2015-2020)
  • Table 85. France Transfection Reagents, by Application USD Million (2015-2020)
  • Table 86. France Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 87. France Transfection Reagents, by Method USD Million (2015-2020)
  • Table 88. Italy Transfection Reagents, by Type USD Million (2015-2020)
  • Table 89. Italy Transfection Reagents, by Application USD Million (2015-2020)
  • Table 90. Italy Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 91. Italy Transfection Reagents, by Method USD Million (2015-2020)
  • Table 92. United Kingdom Transfection Reagents, by Type USD Million (2015-2020)
  • Table 93. United Kingdom Transfection Reagents, by Application USD Million (2015-2020)
  • Table 94. United Kingdom Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 95. United Kingdom Transfection Reagents, by Method USD Million (2015-2020)
  • Table 96. Netherlands Transfection Reagents, by Type USD Million (2015-2020)
  • Table 97. Netherlands Transfection Reagents, by Application USD Million (2015-2020)
  • Table 98. Netherlands Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 99. Netherlands Transfection Reagents, by Method USD Million (2015-2020)
  • Table 100. Rest of Europe Transfection Reagents, by Type USD Million (2015-2020)
  • Table 101. Rest of Europe Transfection Reagents, by Application USD Million (2015-2020)
  • Table 102. Rest of Europe Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 103. Rest of Europe Transfection Reagents, by Method USD Million (2015-2020)
  • Table 104. MEA Transfection Reagents, by Country USD Million (2015-2020)
  • Table 105. MEA Transfection Reagents, by Type USD Million (2015-2020)
  • Table 106. MEA Transfection Reagents, by Application USD Million (2015-2020)
  • Table 107. MEA Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 108. MEA Transfection Reagents, by Method USD Million (2015-2020)
  • Table 109. Middle East Transfection Reagents, by Type USD Million (2015-2020)
  • Table 110. Middle East Transfection Reagents, by Application USD Million (2015-2020)
  • Table 111. Middle East Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 112. Middle East Transfection Reagents, by Method USD Million (2015-2020)
  • Table 113. Africa Transfection Reagents, by Type USD Million (2015-2020)
  • Table 114. Africa Transfection Reagents, by Application USD Million (2015-2020)
  • Table 115. Africa Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 116. Africa Transfection Reagents, by Method USD Million (2015-2020)
  • Table 117. North America Transfection Reagents, by Country USD Million (2015-2020)
  • Table 118. North America Transfection Reagents, by Type USD Million (2015-2020)
  • Table 119. North America Transfection Reagents, by Application USD Million (2015-2020)
  • Table 120. North America Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 121. North America Transfection Reagents, by Method USD Million (2015-2020)
  • Table 122. United States Transfection Reagents, by Type USD Million (2015-2020)
  • Table 123. United States Transfection Reagents, by Application USD Million (2015-2020)
  • Table 124. United States Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 125. United States Transfection Reagents, by Method USD Million (2015-2020)
  • Table 126. Canada Transfection Reagents, by Type USD Million (2015-2020)
  • Table 127. Canada Transfection Reagents, by Application USD Million (2015-2020)
  • Table 128. Canada Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 129. Canada Transfection Reagents, by Method USD Million (2015-2020)
  • Table 130. Mexico Transfection Reagents, by Type USD Million (2015-2020)
  • Table 131. Mexico Transfection Reagents, by Application USD Million (2015-2020)
  • Table 132. Mexico Transfection Reagents, by End Users USD Million (2015-2020)
  • Table 133. Mexico Transfection Reagents, by Method USD Million (2015-2020)
  • Table 134. Transfection Reagents: by Type(USD/Units)
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Transfection Reagents: by Type(USD Million)
  • Table 146. Transfection Reagents Reagents , by Region USD Million (2021-2026)
  • Table 147. Transfection Reagents Instruments , by Region USD Million (2021-2026)
  • Table 148. Transfection Reagents: by Application(USD Million)
  • Table 149. Transfection Reagents Biomedical Research , by Region USD Million (2021-2026)
  • Table 150. Transfection Reagents Gene Expression Studies , by Region USD Million (2021-2026)
  • Table 151. Transfection Reagents Cancer Research , by Region USD Million (2021-2026)
  • Table 152. Transfection Reagents Transgenic Model , by Region USD Million (2021-2026)
  • Table 153. Transfection Reagents Protein Production , by Region USD Million (2021-2026)
  • Table 154. Transfection Reagents Therapeutic Delivery , by Region USD Million (2021-2026)
  • Table 155. Transfection Reagents: by End Users(USD Million)
  • Table 156. Transfection Reagents Academic & Research Institutes , by Region USD Million (2021-2026)
  • Table 157. Transfection Reagents Pharmaceutical & Biotechnology Companies , by Region USD Million (2021-2026)
  • Table 158. Transfection Reagents: by Method(USD Million)
  • Table 159. Transfection Reagents Biochemical , by Region USD Million (2021-2026)
  • Table 160. Transfection Reagents Calcium Phosphate , by Region USD Million (2021-2026)
  • Table 161. Transfection Reagents Lipofection , by Region USD Million (2021-2026)
  • Table 162. Transfection Reagents DEAE-dextran , by Region USD Million (2021-2026)
  • Table 163. Transfection Reagents Dendrimers , by Region USD Million (2021-2026)
  • Table 164. Transfection Reagents Physical , by Region USD Million (2021-2026)
  • Table 165. Transfection Reagents Electroporation , by Region USD Million (2021-2026)
  • Table 166. Transfection Reagents Nucleofection , by Region USD Million (2021-2026)
  • Table 167. Transfection Reagents Viral , by Region USD Million (2021-2026)
  • Table 168. Transfection Reagents Others , by Region USD Million (2021-2026)
  • Table 169. South America Transfection Reagents, by Country USD Million (2021-2026)
  • Table 170. South America Transfection Reagents, by Type USD Million (2021-2026)
  • Table 171. South America Transfection Reagents, by Application USD Million (2021-2026)
  • Table 172. South America Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 173. South America Transfection Reagents, by Method USD Million (2021-2026)
  • Table 174. Brazil Transfection Reagents, by Type USD Million (2021-2026)
  • Table 175. Brazil Transfection Reagents, by Application USD Million (2021-2026)
  • Table 176. Brazil Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 177. Brazil Transfection Reagents, by Method USD Million (2021-2026)
  • Table 178. Argentina Transfection Reagents, by Type USD Million (2021-2026)
  • Table 179. Argentina Transfection Reagents, by Application USD Million (2021-2026)
  • Table 180. Argentina Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 181. Argentina Transfection Reagents, by Method USD Million (2021-2026)
  • Table 182. Rest of South America Transfection Reagents, by Type USD Million (2021-2026)
  • Table 183. Rest of South America Transfection Reagents, by Application USD Million (2021-2026)
  • Table 184. Rest of South America Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 185. Rest of South America Transfection Reagents, by Method USD Million (2021-2026)
  • Table 186. Asia Pacific Transfection Reagents, by Country USD Million (2021-2026)
  • Table 187. Asia Pacific Transfection Reagents, by Type USD Million (2021-2026)
  • Table 188. Asia Pacific Transfection Reagents, by Application USD Million (2021-2026)
  • Table 189. Asia Pacific Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 190. Asia Pacific Transfection Reagents, by Method USD Million (2021-2026)
  • Table 191. China Transfection Reagents, by Type USD Million (2021-2026)
  • Table 192. China Transfection Reagents, by Application USD Million (2021-2026)
  • Table 193. China Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 194. China Transfection Reagents, by Method USD Million (2021-2026)
  • Table 195. Japan Transfection Reagents, by Type USD Million (2021-2026)
  • Table 196. Japan Transfection Reagents, by Application USD Million (2021-2026)
  • Table 197. Japan Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 198. Japan Transfection Reagents, by Method USD Million (2021-2026)
  • Table 199. India Transfection Reagents, by Type USD Million (2021-2026)
  • Table 200. India Transfection Reagents, by Application USD Million (2021-2026)
  • Table 201. India Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 202. India Transfection Reagents, by Method USD Million (2021-2026)
  • Table 203. South Korea Transfection Reagents, by Type USD Million (2021-2026)
  • Table 204. South Korea Transfection Reagents, by Application USD Million (2021-2026)
  • Table 205. South Korea Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 206. South Korea Transfection Reagents, by Method USD Million (2021-2026)
  • Table 207. Taiwan Transfection Reagents, by Type USD Million (2021-2026)
  • Table 208. Taiwan Transfection Reagents, by Application USD Million (2021-2026)
  • Table 209. Taiwan Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 210. Taiwan Transfection Reagents, by Method USD Million (2021-2026)
  • Table 211. Australia Transfection Reagents, by Type USD Million (2021-2026)
  • Table 212. Australia Transfection Reagents, by Application USD Million (2021-2026)
  • Table 213. Australia Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 214. Australia Transfection Reagents, by Method USD Million (2021-2026)
  • Table 215. Rest of Asia-Pacific Transfection Reagents, by Type USD Million (2021-2026)
  • Table 216. Rest of Asia-Pacific Transfection Reagents, by Application USD Million (2021-2026)
  • Table 217. Rest of Asia-Pacific Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 218. Rest of Asia-Pacific Transfection Reagents, by Method USD Million (2021-2026)
  • Table 219. Europe Transfection Reagents, by Country USD Million (2021-2026)
  • Table 220. Europe Transfection Reagents, by Type USD Million (2021-2026)
  • Table 221. Europe Transfection Reagents, by Application USD Million (2021-2026)
  • Table 222. Europe Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 223. Europe Transfection Reagents, by Method USD Million (2021-2026)
  • Table 224. Germany Transfection Reagents, by Type USD Million (2021-2026)
  • Table 225. Germany Transfection Reagents, by Application USD Million (2021-2026)
  • Table 226. Germany Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 227. Germany Transfection Reagents, by Method USD Million (2021-2026)
  • Table 228. France Transfection Reagents, by Type USD Million (2021-2026)
  • Table 229. France Transfection Reagents, by Application USD Million (2021-2026)
  • Table 230. France Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 231. France Transfection Reagents, by Method USD Million (2021-2026)
  • Table 232. Italy Transfection Reagents, by Type USD Million (2021-2026)
  • Table 233. Italy Transfection Reagents, by Application USD Million (2021-2026)
  • Table 234. Italy Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 235. Italy Transfection Reagents, by Method USD Million (2021-2026)
  • Table 236. United Kingdom Transfection Reagents, by Type USD Million (2021-2026)
  • Table 237. United Kingdom Transfection Reagents, by Application USD Million (2021-2026)
  • Table 238. United Kingdom Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 239. United Kingdom Transfection Reagents, by Method USD Million (2021-2026)
  • Table 240. Netherlands Transfection Reagents, by Type USD Million (2021-2026)
  • Table 241. Netherlands Transfection Reagents, by Application USD Million (2021-2026)
  • Table 242. Netherlands Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 243. Netherlands Transfection Reagents, by Method USD Million (2021-2026)
  • Table 244. Rest of Europe Transfection Reagents, by Type USD Million (2021-2026)
  • Table 245. Rest of Europe Transfection Reagents, by Application USD Million (2021-2026)
  • Table 246. Rest of Europe Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 247. Rest of Europe Transfection Reagents, by Method USD Million (2021-2026)
  • Table 248. MEA Transfection Reagents, by Country USD Million (2021-2026)
  • Table 249. MEA Transfection Reagents, by Type USD Million (2021-2026)
  • Table 250. MEA Transfection Reagents, by Application USD Million (2021-2026)
  • Table 251. MEA Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 252. MEA Transfection Reagents, by Method USD Million (2021-2026)
  • Table 253. Middle East Transfection Reagents, by Type USD Million (2021-2026)
  • Table 254. Middle East Transfection Reagents, by Application USD Million (2021-2026)
  • Table 255. Middle East Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 256. Middle East Transfection Reagents, by Method USD Million (2021-2026)
  • Table 257. Africa Transfection Reagents, by Type USD Million (2021-2026)
  • Table 258. Africa Transfection Reagents, by Application USD Million (2021-2026)
  • Table 259. Africa Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 260. Africa Transfection Reagents, by Method USD Million (2021-2026)
  • Table 261. North America Transfection Reagents, by Country USD Million (2021-2026)
  • Table 262. North America Transfection Reagents, by Type USD Million (2021-2026)
  • Table 263. North America Transfection Reagents, by Application USD Million (2021-2026)
  • Table 264. North America Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 265. North America Transfection Reagents, by Method USD Million (2021-2026)
  • Table 266. United States Transfection Reagents, by Type USD Million (2021-2026)
  • Table 267. United States Transfection Reagents, by Application USD Million (2021-2026)
  • Table 268. United States Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 269. United States Transfection Reagents, by Method USD Million (2021-2026)
  • Table 270. Canada Transfection Reagents, by Type USD Million (2021-2026)
  • Table 271. Canada Transfection Reagents, by Application USD Million (2021-2026)
  • Table 272. Canada Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 273. Canada Transfection Reagents, by Method USD Million (2021-2026)
  • Table 274. Mexico Transfection Reagents, by Type USD Million (2021-2026)
  • Table 275. Mexico Transfection Reagents, by Application USD Million (2021-2026)
  • Table 276. Mexico Transfection Reagents, by End Users USD Million (2021-2026)
  • Table 277. Mexico Transfection Reagents, by Method USD Million (2021-2026)
  • Table 278. Transfection Reagents: by Type(USD/Units)
  • Table 279. Research Programs/Design for This Report
  • Table 280. Key Data Information from Secondary Sources
  • Table 281. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Transfection Reagents: by Type USD Million (2015-2020)
  • Figure 5. Global Transfection Reagents: by Application USD Million (2015-2020)
  • Figure 6. Global Transfection Reagents: by End Users USD Million (2015-2020)
  • Figure 7. Global Transfection Reagents: by Method USD Million (2015-2020)
  • Figure 8. South America Transfection Reagents Share (%), by Country
  • Figure 9. Asia Pacific Transfection Reagents Share (%), by Country
  • Figure 10. Europe Transfection Reagents Share (%), by Country
  • Figure 11. MEA Transfection Reagents Share (%), by Country
  • Figure 12. North America Transfection Reagents Share (%), by Country
  • Figure 13. Global Transfection Reagents: by Type USD/Units (2015-2020)
  • Figure 14. Global Transfection Reagents share by Players 2020 (%)
  • Figure 15. Global Transfection Reagents share by Players (Top 3) 2020(%)
  • Figure 16. Global Transfection Reagents share by Players (Top 5) 2020(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2020
  • Figure 20. Promega Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 21. Promega Corporation (United States) Revenue: by Geography 2020
  • Figure 22. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2020
  • Figure 24. QIAGEN N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 25. QIAGEN N.V. (Netherlands) Revenue: by Geography 2020
  • Figure 26. Polyplus-transfection SA (France) Revenue, Net Income and Gross profit
  • Figure 27. Polyplus-transfection SA (France) Revenue: by Geography 2020
  • Figure 28. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 29. Bio-Rad Laboratories (United States) Revenue: by Geography 2020
  • Figure 30. Lonza Group (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. Lonza Group (Switzerland) Revenue: by Geography 2020
  • Figure 32. Sigma-Aldrich Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Sigma-Aldrich Corporation (United States) Revenue: by Geography 2020
  • Figure 34. Mirus Bio LLC (United States) Revenue, Net Income and Gross profit
  • Figure 35. Mirus Bio LLC (United States) Revenue: by Geography 2020
  • Figure 36. MaxCyte Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. MaxCyte Inc. (United States) Revenue: by Geography 2020
  • Figure 38. Global Transfection Reagents: by Type USD Million (2021-2026)
  • Figure 39. Global Transfection Reagents: by Application USD Million (2021-2026)
  • Figure 40. Global Transfection Reagents: by End Users USD Million (2021-2026)
  • Figure 41. Global Transfection Reagents: by Method USD Million (2021-2026)
  • Figure 42. South America Transfection Reagents Share (%), by Country
  • Figure 43. Asia Pacific Transfection Reagents Share (%), by Country
  • Figure 44. Europe Transfection Reagents Share (%), by Country
  • Figure 45. MEA Transfection Reagents Share (%), by Country
  • Figure 46. North America Transfection Reagents Share (%), by Country
  • Figure 47. Global Transfection Reagents: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific Inc. (United States)
  • Promega Corporation (United States)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • QIAGEN N.V. (Netherlands)
  • Polyplus-transfection SA (France)
  • Bio-Rad Laboratories (United States)
  • Lonza Group (Switzerland)
  • Sigma-Aldrich Corporation (United States)
  • Mirus Bio LLC (United States)
  • MaxCyte Inc. (United States)
Select User Access Type

Key Highlights of Report


Jun 2021 206 Pages 94 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Transfection Reagents Market Quantitative research analysis
Global Transfection Reagents Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Transfection Reagents study can be customized to meet your requirements. The market size breakdown by type [Reagents and Instruments], by end use application [Biomedical Research, Gene Expression Studies, Cancer Research, Transgenic Model, Protein Production and Therapeutic Delivery].
The Transfection Reagents Market is gaining popularity and expected to see strong valuation by 2026.
According to AMA, the Global Transfection Reagents market is expected to see growth rate of 7.4%.

Know More About Global Transfection Reagents Market Report?

Have a Query? Click Here

Other Related Reports

Radiopharmaceuticals in Nuclear Medicine Comprehensive Study by Type (Diagnostic Nuclear Medicine (PECT Radiopharmaceuticals, PET Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters, ...
$ 3750
Cosmetic Implants Comprehensive Study by Type (Breast Implants, Dental Implants, Facial Implants, Others), Application (Hospital, Cosmetic Club), Material (Polymers, Metal Implants, Bio Material, Cer...
$ 3500
Slide Stainer Comprehensive Study by Type (Reagent, Equipment {Automated, Manual}, Consumables & Accessories), End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Phar...
$ 3750
Microbial Products Comprehensive Study by Type (Enzymes, Polysaccharides, Nutrients ( (Amino Acids, Nucleotides, Vitamins, And Organic Acids), Chemotherapeutic Agents, Vaccines, Antibiotics, Others),...
$ 3750
Metabotropic Glutamate Receptor Comprehensive Study by Type (MGluR2 , MGluR4 , MGluR5), Application (Attention Deficit Hyperactivity Disorder , Alzheimer's Disease , Chronic Obstructive Pulmonary Dis...
$ 3500
Protective Cultures Comprehensive Study by Type (Pure Culture, Mixed Culture), Application (Dairy Based Products, Meat & poultry Products, Seafood, Bakery & Confectioneries, RTE Food Products, Bevera...
$ 3650